Highly Efficient Olefin-Metathesis Catalysts - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Highly Efficient Olefin-Metathesis Catalysts
The authors describe the Piers' catalysts and detail latest progress in olefin-metathesis catalyst technology.


Pharmaceutical Technology


7. S.R. Dubberley et al., "Synthesis, Characterization and Olefin Metathesis Studies of a Family of Ruthenium Phosphonium Alkylidene Complexes," Inorg. Chim. Acta. 359 (9), 2658–2664 (2006).

8. P.E. Romero and W.E. Piers, "Direct Observation of a 14-Electron Ruthenacyclobutane Relevant to Olefin Metathesis," J. Am. Chem. Soc. 127 (14), 5032–5033 (2005).

9. C. W. Lee et al., "Impurity Reduction in Olefin Metathesis Reactions," US Patent Application US2005/0203324 A1 (Priority Date Aug. 23, 2004, released Sept. 15, 2005).

10. B.P. Paulson and R.L. Pederson, "Impurity Inhibition in Olefin-Metathesis Reactions," US Patent 6,900,347, issued May 31, 2005.

11. R.L. Pederson and B. P. Paulson, "Impurity Inhibition in Olefin-Metathesis Reactions," WO 02094748, A1 Priority Date May 24, 2001.

12. R.L. Pederson et al., "Applications of Olefin Cross Metathesis to Commercial Products," Adv. Synth. Catal. 344 (6–7), 728–735 (2002).

13. K.C. Nicolaou, A. Ortiz, and R.M. Denton, "Metathesis Reaction in the Synthesis of Complex Molecules," Chem. Today 25 (5), 70–76 (2007).

14. D.J. Wallace et al., "A Double Ring Closing Metathesis Reaction in the Rapid, Enantioselective Synthesis of NK-1 Receptor Antagonists," Org. Lett. 3 (5), 671–674 (2001).

15. R.M. Kanada et al., "Total Synthesis of the Potent Antitumor macrolides Pladienolide B and D," Angew. Chem., Int. Ed. 46 (23), 4350–4355 (2007).

16. P. Schwab, R.H. Grubbs, and J.W. Ziller, "Synthesis and Applications of RuCl2 (=CHR')(PR3)2: The Influence of the Alkylidene Moiety on Metathesis Activity," J. Am. Chem. Soc. 118 (1), 100–110 (1996).

17. M. Scholl, S. Ding, C.W. Lee, and R.H. Grubbs, "Synthesis and Activity of a New Generation of Ruthenium-Based Olefin Metathesis Catalysts Coordinated with 1,3-Dimesityl-4,5-dihydroimidazole-2-ylidene Ligands," Org. Lett. 1 (6), 953–956 (1999).

18. S.B. Garber et al., "Efficient and Recyclable Monomeric and Dendritic Ru-Based Metathesis Catalysts," J. Am. Chem. Soc. 122 (34), 8168–8179 (2000).

19. I.C. Stewart et al., "Highly Efficient Ruthenium Catalysts for the Formation of Tetrasubstituted Olefins via Ring-Closing Metathesis," Org. Lett. 9 (8), 1589–1592 (2007).

20. C.K. Chung and R.H. Grubbs, "Olefin Metathesis Catalyst: Stabilization Effect of Backbone Substitutions of N -Heterocyclic Carbene," Org. Lett. 10 (13), 2693–2692 (2008).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
22%
To all process for new products only
12%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here